Russell Ross

Q: What Schools Are Affiliated With Russell Ross

Russell Ross is affiliated with the following schools: Cornell University, University of Washington

Russell Ross's AcademicInfluence.com Rankings

Russell Ross

Biology

#782

World Rank

#1355

Historical Rank

#419

USA Rank

Pathology

World Rank

Historical Rank

USA Rank

biology Degrees

Download Badge

Biology

Why Is Russell Ross Influential?

(Suggest an Edit or Addition)

According to Wikipedia, Russell Ross was an American professor of pathology, known for research on the pathogenesis of atherosclerosis. Education and career Russell Ross grew up in Jacksonville, Florida and graduated from Cornell University in 1951 before earning a degree in dentistry from Columbia University College of Dental Medicine in 1955. In 1958 he became a doctoral student and received a PhD in experimental pathology from the University of Washington at Seattle in 1962. At the University of Washington at Seattle, Dr. Ross joined the faculty of the University of Washington School of Medicine and was appointed Professor of Pathology in 1969. He served as chair of the Department of Pathology and helped to create an important center for research and medical training in vascular biology and pathology.

(See a Problem?)

Russell Ross's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

The pathogenesis of atherosclerosis: a perspective for the 1990s (1993) (11146)
Atherosclerosis is an inflammatory disease. (1998) (9464)
Atherosclerosis--an inflammatory disease. (1999) (5279)
The pathogenesis of atherosclerosis--an update. (1986) (4914)
The pathogenesis of atherosclerosis (first of two parts). (1976) (3077)
The biology of platelet-derived growth factor (1986) (1963)
A platelet-dependent serum factor that stimulates the proliferation of arterial smooth muscle cells in vitro. (1974) (1832)
ApoE-deficient mice develop lesions of all phases of atherosclerosis throughout the arterial tree. (1994) (1723)
The smooth muscle cell in culture. (1979) (1587)
The smooth muscle cell. II. Growth of smooth muscle in culture and formation of elastic fibers. (1971) (1568)
The role of the macrophage in wound repair. A study with hydrocortisone and antimacrophage serum. (1975) (1511)
Atherosclerosis and the Arterial Smooth Muscle Cell (1973) (1401)
The pathogenesis of atherosclerosis (second of two parts). (1976) (1129)
Cell biology of atherosclerosis. (1995) (1066)
Expression and secretion of type beta transforming growth factor by activated human macrophages. (1987) (1025)
Studies of Hypercholesterolemia in the Nonhuman Primate: I. Changes that Lead to Fatty Streak Formation (1984) (1014)
Homocystine-induced arteriosclerosis. The role of endothelial cell injury and platelet response in its genesis. (1976) (973)
Inhibition of neointimal smooth muscle accumulation after angioplasty by an antibody to PDGF (1991) (923)
Upregulation of VCAM-1 and ICAM-1 at atherosclerosis-prone sites on the endothelium in the ApoE-deficient mouse. (1998) (899)
TGF-β induces bimodal proliferation of connective tissue cells via complex control of an autocrine PDGF loop (1990) (786)
A significant part of macrophage-derived growth factor consists of at least two forms of PDGF (1985) (706)
Hyperlipidemia and atherosclerosis. (1976) (700)
PDGF and FGF stimulate wound healing in the genetically diabetic mouse. (1990) (690)
Human atherosclerosis. II. Immunocytochemical analysis of the cellular composition of human atherosclerotic lesions. (1986) (676)
Interleukin-1 mitogenic activity for fibroblasts and smooth muscle cells is due to PDGF-AA. (1989) (662)
Homocystinemia. Vascular injury and arterial thrombosis. (1974) (650)
THE ELASTIC FIBER: I. The Separation and Partial Characterization of its Macromolecular Components (1969) (632)
Visualization of Fibrous Cap Thickness and Rupture in Human Atherosclerotic Carotid Plaque In Vivo With High-Resolution Magnetic Resonance Imaging (2000) (630)
A macrophage-dependent factor that stimulates the proliferation of fibroblasts in vitro. (1976) (587)
Localization of PDGF-B protein in macrophages in all phases of atherogenesis. (1990) (577)
Two different subunits associate to create isoform-specific platelet-derived growth factor receptors. (1989) (571)
Two classes of PDGF receptor recognize different isoforms of PDGF. (1988) (563)
The adhesive and migratory effects of osteopontin are mediated via distinct cell surface integrins. Role of alpha v beta 3 in smooth muscle cell migration to osteopontin in vitro. (1995) (562)
Fibrillar Collagen Inhibits Arterial Smooth Muscle Proliferation through Regulation of Cdk2 Inhibitors (1996) (551)
PLATELET-DERIVED GROWTH FACTOR (1989) (544)
The platelet-derived growth factor (1978) (543)
Studies of Hypercholesterolemia in the Nonhuman Primate: II. Fatty Streak Conversion to Fibrous Plaque (1984) (497)
Atherosclerosis and the arterial smooth muscle cell: Proliferation of smooth muscle is a key event in the genesis of the lesions of atherosclerosis. (1973) (488)
Response to injury and atherogenesis. (1977) (486)
Ganglioside-mediated modulation of cell growth, growth factor binding, and receptor phosphorylation. (1984) (471)
Cleavage of p21Cip1/Waf1 and p27Kip1 mediates apoptosis in endothelial cells through activation of Cdk2: role of a caspase cascade. (1998) (465)
Phenotype-dependent response of cultured aortic smooth muscle to serum mitogens (1981) (460)
Protein kinase A antagonizes platelet-derived growth factor-induced signaling by mitogen-activated protein kinase in human arterial smooth muscle cells. (1993) (449)
Effect of Insulin on the Proliferation of Cultured Primate Arterial Smooth Muscle Cells (1975) (437)
George Lyman Duff Memorial Lecture. Atherosclerosis: a problem of the biology of arterial wall cells and their interactions with blood components. (1981) (437)
Insulin-like growth factor-I and platelet-derived growth factor-BB induce directed migration of human arterial smooth muscle cells via signaling pathways that are distinct from those of proliferation. (1994) (427)
HHF35, a muscle-actin-specific monoclonal antibody. I. Immunocytochemical and biochemical characterization. (1987) (427)
The neutrophilic leukocyte in wound repair a study with antineutrophil serum. (1972) (425)
PDGF B-chain in neurons of the central nervous system, posterior pituitary, and in a transgenic model (1991) (420)
THE FINE STRUCTURE OF ELASTIC FIBERS (1966) (419)
Rous-Whipple Award Lecture. Atherosclerosis: a defense mechanism gone awry. (1993) (393)
Production of platelet-derived growth factor-like molecules by cultured arterial smooth muscle cells accompanies proliferation after arterial injury. (1986) (389)
Platelet-derived growth factor. I. High yield purification and evidence for multiple forms. (1982) (387)
Platelet factors stimulate fibroblasts and smooth muscle cells quiescent in plasma serum to proliferate (1976) (379)
The extracellular glycoprotein SPARC interacts with platelet-derived growth factor (PDGF)-AB and -BB and inhibits the binding of PDGF to its receptors. (1992) (369)
Early changes in phosphatidylinositol and arachidonic acid metabolism in quiescent swiss 3T3 cells stimulated to divide by platelet-derived growth factor. (1981) (366)
Inhibition of mesangial cell proliferation and matrix expansion in glomerulonephritis in the rat by antibody to platelet-derived growth factor (1992) (359)
THE SMOOTH MUSCLE CELL I. In Vivo Synthesis of Connective Tissue Proteins (1971) (353)
Smooth muscle cells and the pathogenesis of the lesions of atherosclerosis. (1993) (353)
Human atherosclerosis. I. Cell constitution and characteristics of advanced lesions of the superficial femoral artery. (1984) (345)
HUMAN WOUND REPAIR (1968) (343)
Fatty streak initiation in Watanabe Heritable Hyperlipemic and comparably hypercholesterolemic fat-fed rabbits. (1987) (331)
THE ELASTIC FIBER A REVIEW (1973) (330)
Induction of transforming growth factor-α in activated human alveolar macrophages (1988) (321)
Similar effects of platelet-derived growth factor and epidermal growth factor on the phosphorylation of tyrosine in cellular proteins (1982) (311)
An endothelial cell-derived growth factor (1980) (309)
Platelet-derived growth factor. II. Specific binding to cultured cells. (1982) (308)
Platelet-derived growth factor (PDGF) and PDGF receptor are induced in mesangial proliferative nephritis in the rat. (1991) (302)
Relation of cholesterol and mevalonic acid to the cell cycle in smooth muscle and swiss 3T3 cells stimulated to divide by platelet-derived growth factor. (1980) (301)
Cloning and expression of a cDNA coding for the human platelet-derived growth factor receptor: evidence for more than one receptor class. (1988) (284)
Cleavage of beta-catenin and plakoglobin and shedding of VE-cadherin during endothelial apoptosis: evidence for a role for caspases and metalloproteinases. (1998) (280)
Immunocytochemical analysis of cellular components in atherosclerotic lesions. Use of monoclonal antibodies with the Watanabe and fat-fed rabbit. (1986) (280)
Biochemical studies of two patients with the gray platelet syndrome. Selective deficiency of platelet alpha granules. (1980) (277)
EXPERIMENTAL ARTERIOSCLEROSIS (1972) (276)
WOUND HEALING AND COLLAGEN FORMATION (1961) (273)
Caspase-mediated Cleavage of Focal Adhesion Kinase pp125FAK and Disassembly of Focal Adhesions in Human Endothelial Cell Apoptosis (1998) (271)
HHF35, a muscle actin-specific monoclonal antibody. II. Reactivity in normal, reactive, and neoplastic human tissues. (1987) (267)
Role of endogenous platelet-derived growth factor in arterial smooth muscle cell migration after balloon catheter injury. (1993) (261)
Degraded Collagen Fragments Promote Rapid Disassembly of Smooth Muscle Focal Adhesions That Correlates with Cleavage of Pp125FAK, Paxillin, and Talin (1999) (260)
WOUND HEALING AND COLLAGEN FORMATION : V. Quantitative Electron Microscope Radioautographic Observations of Proline-H3 Utilization by Fibroblasts (1965) (258)
Effects of growth factors in vivo. I. Cell ingrowth into porous subcutaneous chambers. (1987) (257)
HUMAN WOUND REPAIR (1968) (256)
Effect of sulfinpyrazone on homocysteine-induced endothelial injury and arteriosclerosis in baboons. (1983) (255)
Mechanisms that regulate the cell cycle status of very primitive hematopoietic cells in long-term human marrow cultures. I. Stimulatory role of a variety of mesenchymal cell activators and inhibitory role of TGF-beta. (1990) (247)
Proteoglycan distribution in lesions of atherosclerosis depends on lesion severity, structural characteristics, and the proximity of platelet-derived growth factor and transforming growth factor-beta. (1998) (235)
Inhibition of hypercholesterolemia-induced atherosclerosis in the nonhuman primate by probucol. I. Is the extent of atherosclerosis related to resistance of LDL to oxidation? (1994) (227)
Coordinate control of 3T3 cell proliferation by platelet-derived growth factor and plasma components. (1978) (226)
Wound healing and collagen formation. III. A quantitative radioautographic study of the utilization of proline-H3 in wounds from normal and scorbutic guinea pigs. (1962) (216)
Purification of PDGF-AB and PDGF-BB from human platelet extracts and identification of all three PDGF dimers in human platelets. (1990) (214)
Human platelet-derived growth factor stimulates prostaglandin synthesis by activation and by rapid de novo synthesis of cyclooxygenase. (1985) (213)
Proteoglycans in primate arteries. I. Ultrastructural localization and distribution in the intima (1975) (211)
Serial magnetic resonance imaging of experimental atherosclerosis detects lesion fine structure, progression and complications in vivo (1995) (207)
EFFECTS OF ANTIMICROTUBULAR AGENTS ON THE SECRETION OF COLLAGEN (1974) (207)
Production of platelet-derived growth factor-like molecules and reduced expression of platelet-derived growth factor receptors accompany transformation by a wide spectrum of agents. (1984) (203)
Human monocyte-derived growth factor(s) for mesenchymal cells: Activation of secretion by endotoxin and concanavalin A (1981) (194)
Apoptosis overrides survival signals through a caspase-mediated dominant-negative NF-κB loop (1999) (185)
Atherogenesis during low level hypercholesterolemia in the nonhuman primate. I. Fatty streak formation. (1990) (184)
Compartmentalization of PDGF on extracellular binding sites dependent on exon-6-encoded sequences (1992) (177)
Human atherosclerosis. III. Immunocytochemical analysis of the cell composition of lesions of young adults. (1992) (175)
Fatty streak expansion and maturation in Watanabe Heritable Hyperlipemic and comparably hypercholesterolemic fat-fed rabbits. (1987) (173)
Platelet‐derived Growth Factor (1995) (172)
The platelet-derived growth factor receptor. (1985) (172)
WOUND HEALING AND COLLAGEN FORMATION (1970) (169)
The mitogen-activated protein kinase pathway can mediate growth inhibition and proliferation in smooth muscle cells. Dependence on the availability of downstream targets. (1997) (163)
Platelet-derived growth factor in vivo: levels, activity, and rate of clearance (1984) (159)
Dynamic expression of alpha 1 beta 1 and alpha 2 beta 1 integrin receptors by human vascular smooth muscle cells. Alpha 2 beta 1 integrin is required for chemotaxis across type I collagen-coated membranes. (1994) (155)
Alpha-thrombin induces release of platelet-derived growth factor-like molecule(s) by cultured human endothelial cells (1986) (153)
Modulation of epidermal growth factor receptors on 3T3 cells by platelet-derived growth factor. (1980) (152)
Mediation of pinocytosis in cultured arterial smooth muscle and endothelial cells by platelet-derived growth factor (1978) (152)
EFFECTS OF LONG-TERM EXERCISE ON HUMAN MUSCLE MITOCHONDRIA (1971) (148)
Platelet-derived growth factor stimulates activity of low density lipoprotein receptors. (1980) (146)
Interactions between the receptors for platelet-derived growth factor and epidermal growth factor (1983) (145)
Platelet-derived growth factor. (1989) (142)
The pathogenesis of atherosclerosis (1979) (139)
FINE STRUCTURAL CHANGES IN UTERINE SMOOTH MUSCLE AND FIBROBLASTS IN RESPONSE TO ESTROGEN (1967) (136)
Cellular proliferation in atherosclerosis and hypertension. (1984) (131)
Synthesis of types I and III procollagen and collagen by monkey aortic smooth muscle cells in vitro. (1977) (131)
Proteoglycans in primate arteries. II. Synthesis and secretion of glycosaminoglycans by arterial smooth muscle cells in culture (1975) (127)
Expression of a disintegrin‐like protein in cultured human vascular cells and in vivo (1997) (127)
Lysophosphatidylcholine upregulates the level of heparin-binding epidermal growth factor-like growth factor mRNA in human monocytes. (1994) (126)
Wound healing and collagen formation. II. Fine structure in experimental scurvy. (1962) (125)
Purification of human platelet-derived growth factor. (1985) (124)
Atherogenesis during low level hypercholesterolemia in the nonhuman primate. II. Fatty streak conversion to fibrous plaque. (1990) (121)
THE SMOOTH MUSCLE CELL (1971) (120)
Demonstration of PDGF B-chain mRNA in glomeruli in mesangial proliferative nephritis by in situ hybridization. (1991) (120)
Synthesis of connective tissue macromolecules by smooth muscle. (1979) (120)
Physiological quiescence in plasma‐derived serum: Influence of platelet‐derived growth factor on cell growth in culture (1978) (119)
TNF-alpha stimulation of fibroblast proliferation. Dependence on platelet-derived growth factor (PDGF) secretion and alteration of PDGF receptor expression. (1995) (118)
Hormones and cell culture (1979) (118)
The smooth muscle cell. III. Elastin synthesis in arterial smooth muscle cell culture (1976) (114)
Platelet-derived growth factor and its role in health and disease. (1990) (111)
Activation of coagulation releases endothelial cell mitogens (1986) (110)
Platelet-derived growth factor activity and mRNA expression in healing vascular grafts in baboons. Association in vivo of platelet-derived growth factor mRNA and protein with cellular proliferation. (1991) (109)
The role of endothelial injury and platelet and macrophage interactions in atherosclerosis (1984) (108)
Human atherosclerosis. IV. Immunocytochemical analysis of cell activation and proliferation in lesions of young adults. (1993) (108)
The influence of oxidatively modified low density lipoproteins on expression of platelet-derived growth factor by human monocyte-derived macrophages. (1991) (108)
The eosinophilic leukocyte. Fine structure studies of changes in the uterus during the estrous cycle. (1966) (107)
Studies of morphologically atypical (“sprouting”) cultures of bovine aortic endothelial cells. Growth characteristics and connective tissue protein synthesis (1980) (106)
Characterization of platelet-derived growth factor-stimulated phosphorylation in cell membranes. (1983) (105)
Platelet-derived Growth Factor Stimulates Protein Kinase A through a Mitogen-activated Protein Kinase-dependent Pathway in Human Arterial Smooth Muscle Cells (*) (1996) (101)
Mechanisms of atherosclerosis--a review. (1990) (100)
Plasma binding proteins for platelet-derived growth factor that inhibit its binding to cell-surface receptors. (1984) (98)
Platelet-derived growth factor. III. Identification of a platelet-derived growth factor receptor by affinity labeling. (1982) (94)
Derivation and properties of platelet-derived growth factor-independent rat smooth muscle cells. (1990) (93)
Biology of atherosclerotic plaque formation: possible role of growth factors in lesion development and the potential impact of soy. (1995) (93)
Collagen synthesis by monkey arterial smooth muscle cells during proliferation and quiescence in culture. (1977) (92)
Atherosclerosis: current understanding of mechanisms and future strategies in therapy. (1993) (91)
Blockade of platelet-derived growth factor or its receptors transiently delays but does not prevent fibrous cap formation in ApoE null mice. (2002) (90)
Platelet-derived growth factor in vivo: levels, activity, and rate of clearance. (1984) (90)
Methods for studying the platelet-derived growth factor receptor. (1985) (89)
Electron Microscopy: Attachment Sites between Connective Tissue Cells (1966) (89)
Vascular effects of cyclosporine A in vivo and in vitro. (1990) (88)
THE ELASTIC FIBER (1969) (86)
Platelet-derived growth factor B-chain-like immunoreactivity in the developing and adult rat brain. (1992) (86)
Role of serum components in density-dependent inhibition of growth of cells in culture. Platelet-derived growth factor is the major serum determinant of saturation density (1980) (86)
Induction of transforming growth factor-alpha in activated human alveolar macrophages. (1988) (85)
Basis of hematopoietic defects in platelet-derived growth factor (PDGF)-B and PDGF beta-receptor null mice. (2001) (85)
WOUND HEALING AND COLLAGEN FORMATION (1964) (84)
Relative platelet-derived growth factor receptor subunit expression determines cell migration to different dimeric forms of PDGF. (1990) (83)
Apoptosis overrides survival signals through a caspase-mediated dominant-negative NF-kappa B loop. (1999) (83)
Constitutive and inducible secretion of platelet-derived growth factor analogs by human leukemic cell lines coexpressing erythroid and megakaryocytic markers. (1987) (82)
Inhibition of PDGF‐stimulated and matrix‐mediated proliferation of human vascular smooth muscle cells by SPARC is independent of changes in cell shape or cyclin‐dependent kinase inhibitors (2002) (81)
Balloon catheter de-endothelialization of the nude rat carotid. Response to injury in the absence of functional T lymphocytes. (1991) (81)
Biochemical properties of the endothelium‐derived growth factor: Comparision to other growth factors (1983) (78)
Synthesis, phosphorylation, and degradation of multiple forms of the platelet-derived growth factor receptor studied using a monoclonal antibody. (1987) (77)
Elastic fibers in the body. (1971) (77)
A presumptive subunit of elastic fiber microfibrils secreted by arterial smooth-muscle cells in culture. (1976) (76)
The arterial wall and atherosclerosis. (1979) (74)
Activation of metalloproteinases and their association with integrins: an auxiliary apoptotic pathway in human endothelial cells (2002) (73)
Platelet‐derived growth factor: Morphologic and biochemical studies of binding, internalization, and degradation (1984) (73)
The morphogenesis of elastic fibers. (1977) (72)
Inhibition of hypercholesterolemia-induced atherosclerosis in the nonhuman primate by probucol. II. Cellular composition and proliferation. (1995) (72)
Platelet-derived growth factor enhances in vitro erythropoiesis via stimulation of mesenchymal cells. (1985) (71)
Location of procollagen in chick corneal and tendon fibroblasts with ferritin-conjugated antibodies (1975) (71)
Regional expression of the platelet-derived growth factor and its receptors in a primate graft model of vessel wall assembly. (1993) (69)
Cellular Interactions, Growth Factors, and Smooth Muscle Proliferation in Atherogenesis a (1990) (69)
Isolation, characterization, and propagation in vitro of human glomerular endothelial cells (1984) (69)
Cellular and molecular studies of atherogenesis. (1997) (68)
A study of the Influence of mevalonic acid and its metabolites on the morphology of swiss 3T3 cells (1982) (67)
Connective tissue cells, cell proliferation and synthesis of extracellular matrix-a review. (1975) (66)
ADAM15 overexpression in NIH3T3 cells enhances cell-cell interactions. (2001) (65)
Glucocorticoid inhibits thrombin-induced expression of platelet-derived growth factor A-chain and heparin-binding epidermal growth factor-like growth factor in human aortic smooth muscle cells. (1993) (64)
The process of atherogenesis — cellular and molecular interaction: from experimental animal models to humans (1992) (64)
Effects of heterologous antineutrophil serum in guinea pigs. Hematologic and ultrastructural observations. (1971) (64)
Growth Regulatory Mechanisms and Formation of the Lesions of Atherosclerosis a (1994) (62)
ROLE OF THE PLATELET IN ATHEROGENESIS * (1976) (61)
Locally acting growth factors for vascular smooth muscle cells: endogenous synthesis and release from platelets. (1985) (61)
Multiple growth factors are associated with lesions of atherosclerosis: Specificity or redundancy? (1996) (61)
MMP9 production by human monocyte-derived macrophages is decreased on polymerized type I collagen. (2001) (59)
Biology of the interleukin-1 receptor. (1990) (54)
The Role of Endothelial Cell Injury and Platelet Response in Atherogenesis (1977) (51)
Magnetic resonance imaging to study lesions of atherosclerosis in the hyperlipidemic rabbit aorta. (1996) (51)
Polypeptide growth factors and atherosclerosis. (1991) (50)
Responsiveness of the in vitro hematopoietic microenvironment to platelet-derived growth factor. (1985) (49)
Genetically modified mice as models of transplant atherosclerosis (1996) (42)
Studies of primate arterial smooth muscle cells in relation to atherosclerosis. (1974) (41)
Platelets: cell proliferation and atherosclerosis. (1979) (40)
Low density lipoprotein receptor-dependent prostaglandin synthesis in Swiss 3T3 cells stimulated by platelet-derived growth factor. (1986) (39)
Platelet-derived growth factor (PDGF) receptor alpha-subunit mutant and reconstituted cell lines demonstrate that transforming growth factor-beta can be mitogenic through PDGF A-chain-dependent and -independent pathways. (1994) (38)
The B chain of PDGF alone is sufficient for mitogenesis. (1985) (37)
Vascular cell adhesion molecule-1 is induced on endothelium during acute rejection in human cardiac allografts. (1992) (37)
Platelet-derived growth factor: its potential roles in wound healing, atherosclerosis, neoplasia, and growth and development. (1985) (37)
IS023 Cleavage of p21^ and p27^ Mediates Apoptosis in Endothelial Cells Through Activation of Cdk2: Role of a Caspase-3-like Caspase Cascade (1998) (37)
Growth Factors With Heparin Binding Affinity In Human Synovial Fluid (1987) (35)
AUTORADIOGRAPHIC LOCALIZATION OF LIPID- AND WATER-SOLUBLE COMPOUNDS: A NEW APPROACH (1965) (35)
Platelets, Macrophages, Endothelium, and Growth Factors Their Effects upon Cells and their Possible Roles in Atherogenesis (1985) (35)
Multiple Receptors on Human Monocytes Are Involved in Adhesion to Cultured Human Endothelial Cells (1990) (35)
Partial characterization of the shift from IgG to IgA synthesis in the clonal differentiation of human leukemic bone marrow-derived lymphocytes (1975) (35)
Endothelium and arteriosclerosis. (1981) (34)
The production and secretion of procollagen peptidase by human fibroblasts in culture. (1973) (34)
Lipid Composition of Aorta of Watanabe Heritable Hyperlipemic and Comparably Hypercholesterolemic Fat‐fed Rabbits: Plasma Lipid Composition Determines Aortic Lipid Composition of Hypercholesterolemic Rabbits (1988) (33)
Pathogenesis of arterial vascular disease. (2008) (33)
Fine structure alterations of elastic fibers in pseudoxanthoma elasticum (1978) (33)
GROWTH FACTORS FROM PLATELETS, MONOCYTES, AND ENDOTHELIUM: THEIR ROLE IN CELL PROLIFERATION * (1982) (33)
Atherosclerosis: a question of endothelial integrity and growth control of smooth muscle. (1981) (32)
Platelet proteins, including platelet-derived growth factor, specifically depress a subset of the multiple components of the response elicited by glutathione in Hydra (1987) (32)
Interaction of platelets with the vessel wall (1985) (32)
The effect of complement depletion on wound healing. (1974) (32)
a-Thrombin Induces Release of Platelet-derived Growth Factor-like Molecule(s) by Cultured Human Endothelial Cells (1986) (31)
Is epidermal growth factor present in human blood? Interference with the radioreceptor assay for epidermal growth factor. (1983) (31)
Growth-mediated, density-dependent inhibition of endocytosis in cultured arterial smooth muscle cells. (1980) (31)
An Introduction to Vascular Biology (1998) (30)
Atherosclerosis: the role of endothelial injury, smooth muscle proliferation and platelet factors. (1976) (29)
8 Platelet-derived growth factor (1984) (28)
Analysis of the mitogenic effect of fetuin preparations on arterial smooth muscle cells: The role of contaminant platelet‐derived growth factor (1985) (28)
Olfactory ensheathing glia and platelet-derived growth factor B-chain reactivity in the transplanted rat olfactory bulb (1994) (26)
Two cholesterol ester hydrolases. Distribution in rat tissues and in cultured human fibroblasts and monkey arterial smooth muscle cells. (1977) (26)
A radioautographic study of collagen synthesis by earthworm epidermis. (1975) (22)
WOUND HEALING AND COLLAGEN FORMATION (1965) (20)
ENDOTHELIAL INJURY: BLOOD‐VESSEL WALL INTERACTIONS * (1982) (20)
Platelets, Platelet‐Derived Growth Factor, Growth Control, and their Interactions with the Vascular Wall (1985) (20)
The role of T lymphocytes in inflammation. (1994) (20)
Expression of platelet-derived growth factor and its receptors by two pre-B acute lymphocytic leukemia cell lines. (1994) (19)
Preliminary Studies on Mechanochemical-structure Relationships in Connective Tissues Using Enzymolysis Techniques (1973) (19)
Platelet-derived growth factor--its role in health and disease. (1988) (19)
THE EOSINOPHILIC LEUKOCYTE (1966) (18)
The Platelet-Derived Growth Factor Review (1978) (17)
The Platelet Derived Growth Factor and Cell Proliferation (1979) (16)
Regulation of glycogen synthase activity by growth factors. Relationship between synthase activation and receptor occupancy. (1987) (16)
Is Overamplification of the Normal Macrophage Defensive Role Critical to Lesion Development? a (1997) (14)
SYNTHESIS AND SECRETION OF COLLAGEN BY FIBROBLASTS IN HEALING WOUNDS1 (1965) (14)
Plaque-associated immune reactivity as a tool for the diagnosis and treatment of atherosclerosis. (1992) (14)
Identification and assay of platelet-derived growth factor-binding proteins. (1987) (13)
The effects of different growth factors in subcutaneous wound chambers. (1988) (13)
Role of platelet factors in the growth of cells in culture. (1978) (13)
10 – The Platelet-Derived Growth Factor Receptor (1985) (11)
In vivo, Extracellular, Collagen Fibrillogenesis (1963) (11)
Successful growth of tumours (1989) (10)
Platelet-derived growth factor and impaired wound healing. (1991) (10)
Endothelial Injury and Atherosclerosis (1988) (10)
Induction of Transcription and Secretion of TGF-α by Activated Human Monocytes (1991) (10)
Endothelial Dysfunction and Atherosclerosis (1992) (10)
Stimulation of receptor-dependent and receptor-independent pathways of low-density lipoprotein degradation in arterial smooth muscle cells by platelet-derived growth factor. (1988) (9)
Endothelium, monocytes, platelets, and atherosclerosis. (1986) (9)
The Ultrastructure of Fibrogenesis (1966) (8)
Platelets, endothelium, and smooth muscle cells in atherosclerosis. (1978) (8)
Serial Magnetic Resonance Imaging of Experimental Atherosclerosis Allows Visualization of Lesion Characteristics and Lesion Progression in Vivo a (1997) (8)
Biology of atherosclerotic plaque formation (1995) (8)
Three Putative Integrin Ligands Identified in Human Aortic Smooth Muscle Cells (1997) (7)
Detection of dissection and remodeling of atherosclerotic lesions in rabbits after balloon angioplasty by magnetic-resonance imaging (2000) (7)
The Gordon Wilson Lecture: atherosclerosis--a response to injury gone awry. (1982) (7)
The role of the mononuclear phagocyte in primate and rabbit models of atherosclerosis (1985) (7)
Modulation of local concentrations of platelet-derived growth factor. (1989) (7)
Increased fluid pinocytosis, induced by action of platelet-derived growth factor on quiescent arterial smooth muscle cells, does not require increased cholesterol biosynthesis. (1980) (7)
Tumor promoter enhances mitogenesis by PDGF with little effect on PDGF binding (1986) (7)
SELECTIVE EXPRESSION OF PLATELET-DERIVED GROWTH FACTOR B-CHAIN mRNA BY HUMAN ENDOTHELIAL CELLS AND BY HUMAN PERIPHERAL BLOOD MONOCYTES, BUT NOT BY HUMAN SMOOTH MUSCLE CELLS (1987) (6)
Wound healing. (1969) (6)
Fibroblast proliferation induced by blood cells. (1980) (6)
Mechanisms of smooth muscle profileration—the role of cytikines and growth factors: Research initiatives in vascular surgery * (1989) (6)
WOUND HEALING AND COLLAGEN FORMATION (1962) (6)
Wound Healing: Recent Progress—Future Directions (1971) (5)
I. FIBROUS PLAQUE FORMATION IN PRIMATES, AN ELECTRON MICROSCOPE STUDY* (1972) (5)
Angiogenesis. Successful growth of tumours. (1989) (5)
Cytokine interactions and their control (1991) (5)
Recent Progress in Understanding Atherosclerosis (1983) (5)
Vessel injury, thrombosis, and platelet survival. (1978) (5)
AN ENDOTHELIAL CELL-DERIVED GROWTH FACTOR RAPID COMMUNICATIONS (2003) (5)
The Synthesis and Secretion of Sulfated Glycosaminoglycans by Vascular Smooth Muscle Cells in Vitro (1974) (5)
Smooth muscle cell and atherosclerosis. (1975) (5)
StyI RFLP of the human platelet derived growth factor (PDGF) A-chain gene (1990) (5)
HHF35, A Muscle-A ctin-Specific Monoclonal Antibody I. Immunocytochemical and Biochemical Characterization (2007) (4)
Clinical and morphologic findings in hypercholesterolemic non human primates (1991) (4)
LE-1. Cellular and molecular studies of atherosclerosis (1997) (4)
Induction of transcription and secretion of TGF-alpha by activated human monocytes. (1991) (3)
Growth Factors, Inflammation, and Atherosclerosis (1990) (3)
Perspectives in inflammation, neoplasia and vascular cell biology. Abstracts (1985) (3)
Perspectives in inflammation, neoplasia, and vascular cell biology : proceedings of a Triton Biosciences-UCLA Symposium, held in Park City, Utah, February 2-8, 1985 (1987) (3)
THE SMOOTH MUSCLE CELL (1971) (2)
Human A theroscierosis II. Immunocytochemical Analysis of the Cellular Composition of Human Atherosclerotic Lesions (2007) (2)
The platelet-derived growth factor: a perspective. (1981) (2)
Dynamic Expression of alf 13 and a 2 f 31 Integrin Receptors by Human Vascular Smooth Muscle Cells a 2 1 Integrin Is Required for Chemotaxis Across Type I Collagen-Coated Membranes (2007) (2)
Sulphydryl‐mediated vascular disease (1978) (2)
Immunocytochemical Analysis of the Cellular Composition of Atherosclerotic Lesions in the Human Aorta (1990) (2)
Pathophysiology of Atherosclerosis (2003) (2)
A changing approach to atherosclerosis. Results of basic research. (1981) (2)
Pathogenesis of the Lesions of Atherosclerosis (1979) (2)
Atherosclerosis IV: Recent Advances in Atherosclerosis Research : The Fourth Saratoga International Conference on Atherosclerosis (1997) (2)
Growth factor in human peritoneal dialysate a possible source for macrophage derived growth factor (1982) (1)
Low density lipoprotein receptor-dependent prostaglandin synthesis in Swiss 3 T 3 cells stimulated by platelet-derived growth factor ( prostaglandin E 2 / acetylated low density lipoprotein / fluorescent low density lipoprotein / chloroquine ) (1)
Cell Culture and Factors That Stimulate Smooth Muscle Proliferation (1978) (1)
Arterial Wall Cells and Mitogens (1983) (1)
The Role of PDGF in Health and Disease (1987) (1)
The cells involved in the process of wound repair. (1978) (1)
GROWTH FACTORS FROM THE PLATELET, THE MONOCYTE/MACROPHAGE AND THE ENDOTHELIAL CELL: THEIR POTENTIAL ROLE IN BIOLOGY (1981) (1)
Selective expression of mRNA encoding platelet‐derived growth factor B chain following transfection of foreign genes into cell lines derived from baby hamster kidney (1989) (1)
Growth Factors and Atherogenesis (1983) (1)
STUDIES OF COLIAGEN FORMATION DURING RECOVERY FROM SCURVY (1962) (1)
The palatelet-derived growth factor (1978) (1)
The rate of progression of carotid atherosclerosis. (1984) (1)
Arterial Response to Gentle Injury is Modulated by Anti-Pdgf Immunoglobulin in the Nude Rat (1992) (1)
Book Review Wound Healing: Biochemical and clinical aspects Edited by I. Kelman Cohen, Robert F. Diegelmann, and William J. Lindblad. 630 pp., illustrated. Philadelphia, W.B. Saunders, 1992. $115. ISBN 0–7216–2564–9 . (1992) (1)
Irvine H. Page lecture 1981. The lesions of atherosclerosis. (1985) (1)
Aging of the intercellular matrix in relation to the fibroblast Connective tissue forming cells-a retrospective view. (1974) (1)
Book Review Vascular Pathology Edited by W.E. Stehbens and J.T. Lie. 797 pp., illustrated. New York, Chapman & Hall, 1995. $169. 0-412-48640-7 (1995) (0)
Cloning and expression of a cDNA coding for the human platelet-derived growth factor receptor : Evidence for more than one receptor class ( sequence analysis / baby hamster kidney cells / transfection / phosphorylation ) (2003) (0)
Endothelial Injury and Repair (1983) (0)
Multiple responses of connective tissue cells to mitogenic stimulation with platelet-derived growth factor. (1984) (0)
Areas of inflammation Advances in inflammation research. Volume 5. Edited by G. Weissmann. New York: Raven Press. (1983). 220 pp. $39.00 (1983) (0)
Modulation of platelet derived growth factor stimulated mitogenesis (1985) (0)
Development of the Atherosclerotic Lesion (1996) (0)
Anti-platelet-derived growth factor antibody in the treatment of restenosis (1992) (0)
Anti-growth factor antibody in the treatment of vascular stenosis (1992) (0)
Magnetic resonance imaging (MRI) of advanced lesions of atherosclerosis in the rabbit aorta: findings from serial studies (1994) (0)
Evidence for labelling of tRNA by mevalonic acid during G1-S (1980) (0)
Hormones and cell culture : abstracts of papers presented at the Sixth Cold Spring Harbor Conference on Cell Proliferation, August 29-September 3, 1978 (1978) (0)
Antibodies against platelet-derived growth factor in the treatment of restenosis. (1992) (0)
Platelet-derived growth factor. (1987) (0)
IS104 ATHEROSCLEROSIS IS AN INFLAMMATORY DISEASE (1998) (0)
The Role of Endothelial Cell Injury and Platelet Response in Atherogenesis (1978) (0)
Atherogenlc Diet Mixture and Control Diet Ingredient Atherogenic diet Casein , USP Lactalbumin Wheat flour Dextrin Sucrose (2005) (0)
Elimiation of PDGF-B from only the circulating cells of APOE −/− mice significantly impacts atherosclerotic lesion formation (2000) (0)
Immuno-study of PDGF, PDGF Receptor and Cell Kinetics in Atherosclerotic Lesions in Nonhuman Primates: ―細胞動態との関連について― (1993) (0)
Response of connective tissue cells to injury-growth control and connective tissue metabolism. (1977) (0)
Platelet-derived growth factor (PDGF) stimulates glycogen synthase activity in 3T3 cells (1986) (0)
WOUND HEALING AND COLLAGEN FORMATION (1962) (0)
Platelets and the Platelet-Derived Growth Factor in the Pathogenesis of Atherosclerosis (1985) (0)
Constitutive andInducible Secretion ofPlatelet-derived GrowthFactor AnalogsbyHuman LeukemicCellLinesCoexpressingErythroid andMegakaryocytic Markers (1987) (0)
Overview of the Pathogenesis of Atherosclerosis. (1990) (0)
Vascular Smooth Muscle Growth and Atherosclerosis: Foreword to the Swiss Hypertension Workshop (1989) (0)
Atherosclerosis and Restenosis: Vascular Wall Biology and Imaging Symposium (1996) (0)
Recent advances in atherosclerosis. (1978) (0)
Table of Contents (1985) (0)
Molecular Controls of Smooth Muscle Hypertrophy and Hyperplasia: Overview (1995) (0)
Perspectives in wound healing (1990) (0)
Arteriosclerosis: the first 10 years. (1990) (0)
Growth factors and their receptors : genetic control and rational application : proceedings of an Abbott-Cetus-Genentech-Smith, Kline, & French-UCLA Symposium held in Keystone, Colorado, January 24-30, 1988 (1989) (0)
Interactions Among the Inflammatory and Artery Wall Cells and the Connective Tissue (1998) (0)
Mechanisms in the process of atherogenesis (1995) (0)
REGULATION OF GROWTH FACTOR PRODUCTION BY ENDOTHELIAL CELLS IN RESPONSE TO COAGULATION AND INFLAMATORY FACTORS (1987) (0)
Nonhuman Primate Model of Restenosis (1996) (0)
3.E.1 New insights into the mechanisms of atherosclerosis (1997) (0)
Oxidative modification of lipoproteins and their treatment in primates (1994) (0)
Earl Philip Benditt (1996) (0)

This paper list is powered by the following services:

Other Resources About Russell Ross

en.wikipedia.org

What Schools Are Affiliated With Russell Ross?

Russell Ross is affiliated with the following schools: